Read the latest news from Health. Watch out for current health warnings. And find out how you can have your say on issues that affect you.
Australia's medicine and medical devices regulator, the Therapeutic Goods Administration (TGA), has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
The Australian Technical Advisory Group on Immunisation is consulting with stakeholders on proposed changes to meningococcal and Haemophilus influenzae type B vaccination recommendations for inclusion in the Australian Immunisation Handbook.
An Expert Health Panel has been established to advise the Australian Government on the potential health impacts associated with per- and poly-fluoroalkyl substances (PFAS) exposure and to identify priority areas for further research.
All Australian Governments have agreed to initiate the third review of the National Scheme for the Regulation of Gene Technology (the Review). The Review will be led by a working group comprised of senior officials from Commonwealth and state and territory governments.
Following a decision by the European Commission to implement a number of medical device reforms, including to up-classify all surgical mesh medical devices to Class III and to provide patient implant cards and consumer product information for all implantable medical devices.
Pharmaceutical company Novo Nordisk A/S, in consultation with the TGA, has initiated a consumer level recall of some batches of their NovoPen Echo insulin cartridge holder after detecting there is a possibility they may crack or break if exposed to chemicals in certain cleaning agents.
The public and stakeholders now have an additional two weeks to provide input on the national Health Star Rating (HSR) system, as public consultation is extended until 17 August.
Australia’s medicine and medical devices regulator, the TGA, has decided to remove a number of mesh products whose sole use is the treatment of pelvic organ prolapse via transvaginal implantation from the Australian Register of Therapeutic Goods (ARTG).
The best medical advice and research shows that codeine is no better for pain than other over the counter medicines, Australia’s Chief Medical Officer, Professor Brendan Murphy, said today.
Australia’s Chief Medical Officer, Professor Brendan Murphy, has announced that a Voluntary Blood Testing Program for people impacted by PFAS contamination from RAAF Base Tindal in Katherine will begin on Saturday 17 March.
The Department of Health welcomes the Information Commissioner’s final report following his investigation into the department’s release of a sample of data from the Medicare Benefits Scheme (MBS) and Pharmaceutical Benefits Scheme (PBS).
Two cases of multi-drug resistant gonorrhoea have been recently detected in Australia. One case was diagnosed in Western Australia and a second case diagnosed in Queensland.
A national immunisation coverage target provides a goal against which Australia can measure its immunisation coverage. The Global Vaccine Action Plan 2011-2020 encourages countries to demonstrate a commitment to immunisation.
The Department has developed a template which provides a checklist for immunisation providers to consider before vaccinating a patient with Zostavax (pre-vaccination checklist).
From early 2018, young Australians have free access to the new human papillomavirus (HPV) vaccine, Gardasil®9 that protects against more types of HPV infection.
The Australian Government will invest $3 million under the Medical Research Future Fund to advance stem cell research projects for kids.
The South Australian Academic Health Science and Translation Centre will receive funding under the Medical Research Future Fund to deliver new ground breaking medical research projects.
Australian competitors for the Invictus Games Sydney 2018 (IG2018) are in their final stages of preparation. There are just 100 days to go until the opening ceremony on 20 October 2018. Let the countdown begin!
More than $12 million is being provided to two research translation centres through the Medical Research Future Fund to help tackle some of Australia’s big health challenges.